News >

Tracers Increase PET Imaging Sensitivity in Prostate Cancer

Jessica Hergert
Published: Tuesday, Aug 27, 2019

Manoj K. Jain, MD

Manoj K. Jain, MD

The emergence of FDA-approved diagnostic tracers such as C-11 choline and F-18 fluciclovine (Axumin) in novel PET imaging modalities for the detection of biochemical recurrence in prostate cancer signals a shift from conventional imaging methods, said Manoj K. Jain, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™Aug 30, 20201.5
Community Practice Connections™: ASCO Direct™ Highlights – 2019 Official Annual Meeting ReviewAug 30, 20201.5
Publication Bottom Border
Border Publication